Bioray Biotech Co., Ltd (TPEX: 7561)

Bioray Biotech Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 2, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	686	930	901	1,290	826	-
Market Cap Growth	-14.82%	3.17%	-30.18%	56.23%	-	-
Enterprise Value	636	911	896	1,226	756	-
Last Close Price	23.00	30.90	29.76	46.51	29.94	-
PE Ratio	-	-	1802.11	-	-	-
PS Ratio	3.77	4.85	4.73	8.72	5.28	-
PB Ratio	1.65	2.14	2.00	3.55	2.22	-
P/TBV Ratio	2.14	2.15	2.01	3.58	2.26	-
P/OCF Ratio	138.62	-	363.62	146.17	493.43	-
EV/Sales Ratio	3.47	4.75	4.70	8.28	4.84	-
EV/EBITDA Ratio	-	-	56.76	230.50	80.79	-
Debt / Equity Ratio	0.22	0.16	0.22	0.15	0.17	0.17
Debt / EBITDA Ratio	-	13.55	4.68	4.99	4.11	2.85
Asset Turnover	0.33	0.34	0.36	0.31	0.32	0.37
Inventory Turnover	1.89	2.10	2.24	1.72	2.10	2.85
Quick Ratio	2.52	3.52	2.77	2.20	2.33	2.85
Current Ratio	3.36	5.00	3.69	2.83	3.02	3.33
Return on Equity (ROE)	-3.69%	-2.61%	0.12%	-2.16%	-0.38%	3.58%
Return on Assets (ROA)	-2.86%	-2.12%	-0.04%	-1.08%	-0.03%	0.88%
Return on Capital (ROIC)	-3.10%	-2.29%	-0.04%	-1.19%	-0.03%	1.02%
Earnings Yield	-2.28%	-1.24%	0.06%	-0.56%	-0.01%	-
FCF Yield	0.56%	-1.16%	-6.34%	-0.48%	-5.97%	-
Dividend Yield	0.00%	-	0.67%	-	-	-
Payout Ratio	0.00%	-	-	-	-	50.04%
Buyback Yield / Dilution	-1.54%	-7.37%	-4.67%	-0.14%	0.09%	-23.09%
Total Shareholder Return	-1.54%	-7.37%	-3.99%	-0.14%	0.09%	-23.09%

Source: S&P Capital IQ. Standard template. Financial Sources.